Skip to main content

Peer Review reports

From: Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer’s disease: a randomized phase 1 study

Original Submission
25 Apr 2023 Submitted Original manuscript
2 Jun 2023 Reviewed Reviewer Report
21 Jun 2023 Reviewed Reviewer Report
21 Jul 2023 Author responded Author comments - Daizhuang Peng
Resubmission - Version 2
21 Jul 2023 Submitted Manuscript version 2
30 Jul 2023 Reviewed Reviewer Report
4 Oct 2023 Author responded Author comments - Daizhuang Peng
Resubmission - Version 3
4 Oct 2023 Submitted Manuscript version 3
20 Oct 2023 Author responded Author comments - Daizhuang Peng
Resubmission - Version 4
20 Oct 2023 Submitted Manuscript version 4
Publishing
23 Oct 2023 Editorially accepted
23 Nov 2023 Article published 10.1186/s12916-023-03126-9

You can find further information about peer review here.

Back to article page